SCANTILY PAD- acne treatment liquid

Страна: Соединенные Штаты

Язык: английский

Источник: NLM (National Library of Medicine)

Купи это сейчас

Активный ингредиент:

SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)

Доступна с:

Dermala Inc

Администрация маршрут:

TOPICAL

Тип рецепта:

OTC DRUG

Терапевтические показания :

For the treatment of ACNE For the treatment of Acne

Статус Авторизация:

OTC monograph final

Характеристики продукта

                                SCANTILY PAD- ACNE TREATMENT LIQUID
DERMALA INC
----------
Salicylic acid 1% ...........Acne Treatment
For the treatment of ACNE
WARNINGS For external use only. Skin
irritation and dryness is more likely to
occur when using this product if you use
another topical acne medication at the
same time. If irritation occurs, only use
one topical acne medication at a time.
For the treatment of Acne
INACTIVE INGREDIENTS Organic Aloe vera, organic
grain alcohol, cocamidopropyl dimethylamine, SE
Microbiome ComplexTM, sodium hydroxide, organic
lemon essential oil.
DIRECTIONS Cleanse the skin. Use one pad to apply a
thin layer of solution to affected areas. Start with one
application daily, then increase to two times per day
(morning and evening). If dryness or peeling occurs,
reduce application to once a day or every other day.
Test on a small area of skin before applying to face. If
eye contact occurs, flush thoroughly with water.
Keep out of reach of children
SCANTILY PAD
acne treatment liquid
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN OTC DRUG
ITEM CODE (SOURCE)
NDC:81953-100
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)
SALICYLIC ACID
0.01 mg in 1 mg
Dermala Inc
INACTIVE INGREDIENTS
INGREDIENT NAME
STRENGTH
WATER (UNII: 059QF0KO0R)
0.8 mg in 1 mg
PACKAGING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:81953-100-
01
50 mg in 1 JAR; Type 0: Not a Combination
Product
06/01/2021
MARKETING INFORMATION
MARKETING
CATEGORY
APPLICATION NUMBER OR MONOGRAPH
CITATION
MARKETING START
DATE
MARKETING END
DATE
OTC Monograph Drug
M006
06/01/2021
LABELER -
Dermala Inc (079278092)
Revised: 12/2023
                                
                                Прочитать полный документ
                                
                            

Поиск оповещений, связанных с этим продуктом

Просмотр истории документов